Page last updated: 2024-08-21

pyrazines and Hypercholesterolemia

pyrazines has been researched along with Hypercholesterolemia in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	7 (77.78)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (22.22)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kabbara, WK; Ramadan, WH	1
Hildebrandt, GC; Panu, LD; Shahan, JL	1
Bielak, G; Grossmann, G; Miturzyńska-Stryjecka, H; Widomska-Czekajska, T	1
Cummings, MH; Watts, GF	1
Scheen, AJ	1
Collins, SM; Gaw, A; Lindsay, GM; Lorimer, AR; Packard, CJ; Shepherd, J	1
Balogh, Z; Boda, J; Kárpáti, L; Kovács, P; Leövey, A; Paragh, G; Szabó, J	1
Beyer, KH; Chambers, CE; Helm, C; Passananti, GT; Vesell, ES	1
Caslake, MJ; Gaw, A; Griffin, BA; Packard, CJ; Shepherd, J; Yip, B	1

Reviews

1 review(s) available for pyrazines and Hypercholesterolemia

Article	Year
Sitagliptin/Simvastatin: a first combination tablet to treat type 2 diabetes and hypercholesterolemia--a review of its characteristics. Vascular health and risk management, 2015, Volume: 11 Topics: Biomarkers; Blood Glucose; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Combinations; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypoglycemia; Polypharmacy; Pyrazines; Risk Factors; Simvastatin; Sitagliptin Phosphate; Treatment Outcome; Triazoles; Weight Gain	2015

Article

Year

Sitagliptin/Simvastatin: a first combination tablet to treat type 2 diabetes and hypercholesterolemia--a review of its characteristics.

Vascular health and risk management, 2015, Volume: 11

Topics: Biomarkers; Blood Glucose; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Combinations; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypoglycemia; Polypharmacy; Pyrazines; Risk Factors; Simvastatin; Sitagliptin Phosphate; Treatment Outcome; Triazoles; Weight Gain

2015

Trials

1 trial(s) available for pyrazines and Hypercholesterolemia

Article	Year
Pyrazinoylguanidine: antihypertensive, hypocholesterolemic, and renin effects. Journal of clinical pharmacology, 1992, Volume: 32, Issue:12 Topics: Aged; Blood Pressure; Cholesterol; Dose-Response Relationship, Drug; Female; Guanidines; Heart Rate; Humans; Hypercholesterolemia; Hypertension; Lipoproteins, LDL; Male; Middle Aged; Pyrazines; Renin-Angiotensin System; Single-Blind Method	1992

Other Studies

7 other study(ies) available for pyrazines and Hypercholesterolemia

Article	Year
Rhabdomyolysis in a multiple myeloma patient secondary to concurrent treatment with lenalidomide and pravastatin and to lenalidomide alone. International journal of hematology, 2012, Volume: 96, Issue:6 Topics: Amines; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Boronic Acids; Bortezomib; Combined Modality Therapy; Creatine Kinase, MM Form; Cyclohexanecarboxylic Acids; Dexamethasone; Drug Synergism; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Immunologic Factors; Kidney Diseases; Lenalidomide; Melphalan; Middle Aged; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Polyneuropathies; Pravastatin; Pyrazines; Rhabdomyolysis; Thalidomide	2012
[Assessment of hypolipemic action of the preparation olbetam in people with primary hypercholesterolemia]. Wiadomosci lekarskie (Warsaw, Poland : 1960), 1994, Volume: 47, Issue:15-16 Topics: Adult; Aged; Cholesterol; Female; Humans; Hypercholesterolemia; Hypolipidemic Agents; Male; Middle Aged; Pyrazines	1994
Drug treatment of hypercholesterolaemia in a patient with Gilbert's syndrome. Annals of clinical biochemistry, 1994, Volume: 31 ( Pt 4) Topics: Administration, Oral; Bezafibrate; Bilirubin; Colestipol; Gilbert Disease; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipids; Liver; Liver Function Tests; Lovastatin; Male; Middle Aged; Pravastatin; Pyrazines; Simvastatin	1994
[Pharma clinics. Drug of the month. Acipimox (Olbetam)]. Revue medicale de Liege, 1995, Volume: 50, Issue:11 Topics: Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemias; Hypolipidemic Agents; Pyrazines	1995
Metabolism of apolipoprotein B in primary moderate hypercholesterolaemia: effects of acipimox and cholestyramine therapy. European journal of medical research, 1995, Oct-16, Volume: 1, Issue:1 Topics: Adult; Apolipoproteins B; Cholestyramine Resin; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipoproteins, VLDL; Male; Middle Aged; Pyrazines	1995
Treatment possibility of hypercholesterolaemia associated with hypertriglyceridaemia. Acta biologica Hungarica, 1997, Volume: 48, Issue:3 Topics: Apolipoprotein A-I; Blood Glucose; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemias; Hypertriglyceridemia; Hypolipidemic Agents; Lipoproteins, LDL; Male; Middle Aged; Pyrazines; Time Factors; Triglycerides; Uric Acid	1997
Effects of cholestyramine and acipimox on subfractions of plasma low density lipoprotein. Studies in normolipidaemic and hypercholesterolaemic subjects. European journal of clinical investigation, 1992, Volume: 22, Issue:6 Topics: Adult; Centrifugation, Density Gradient; Cholestyramine Resin; Drug Therapy, Combination; Electrophoresis; Female; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipoproteins, LDL; Male; Middle Aged; Pyrazines; Reference Values	1992